|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.18 USD | -3.19% |
|
+2.84% | +16.99% |
| Capitalization | 6.57B 5.65B 5.17B 4.93B 9.04B 630B 9.19B 62.03B 24B 299B 24.66B 24.13B 1,043B | P/E ratio 2026 * |
26.6x | P/E ratio 2027 * | -78.7x |
|---|---|---|---|---|---|
| Enterprise value | 6B 5.16B 4.72B 4.5B 8.25B 575B 8.39B 56.61B 21.91B 273B 22.51B 22.02B 952B | EV / Sales 2026 * |
12x | EV / Sales 2027 * | 42.4x |
| Free-Float |
97.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -3.19% | ||
| 1 week | +2.84% | ||
| Current month | +3.24% | ||
| 1 month | -1.49% | ||
| 3 months | +25.39% | ||
| 6 months | +20.77% | ||
| Current year | +16.99% |
| 1 week | 98.22 |  | 105.72 |
| 1 month | 97 | | 107 |
| Current year | 77 | | 107.84 |
| 1 year | 44.04 | | 107.84 |
| 3 years | 13.72 | | 107.84 |
| 5 years | 6.91 | | 107.84 |
| 10 years | 4.47 | | 107.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 2008-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 2022-04-17 |
Newman Yeilding
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 2008-11-30 |
Harold Selick
CHM | Chairman | 71 | 2014-03-18 |
William Waddill
BRD | Director/Board Member | 68 | 2016-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.19% | +2.84% | +129.67% | +302.28% | 6.57B | |
| -1.01% | -2.82% | -18.17% | -19.32% | 41.67B | |
| -3.73% | -6.04% | +28.41% | +22.76% | 32.6B | |
| -2.55% | +2.71% | +268.39% | +468.32% | 30.97B | |
| -0.91% | -5.37% | +18.41% | -11.55% | 28.23B | |
| -3.23% | -4.84% | +27.50% | +22.65% | 26.41B | |
| -2.03% | +0.77% | - | - | 14.94B | |
| +6.21% | -2.39% | +176.35% | +4,385.95% | 14.13B | |
| -1.92% | -1.95% | +121.19% | +106.25% | 12.27B | |
| -0.20% | -0.10% | +5.63% | -1.89% | 12.12B | |
| Average | -1.26% | -1.37% | +84.15% | +586.16% | 21.99B | |
| Weighted average by Cap. | -1.56% | -2.03% | +71.36% | +390.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 498M 429M 392M 374M 686M 47.82B 697M 4.7B 1.82B 22.7B 1.87B 1.83B 79.08B | 142M 122M 111M 106M 195M 13.59B 198M 1.34B 518M 6.45B 532M 520M 22.48B |
| Net income | 265M 228M 209M 199M 365M 25.46B 371M 2.5B 969M 12.09B 996M 975M 42.11B | -93.35M -80.33M -73.45M -70.08M -128M -8.96B -131M -881M -341M -4.25B -350M -343M -14.81B |
| Net Debt | -574M -494M -452M -431M -790M -55.06B -803M -5.42B -2.1B -26.14B -2.15B -2.11B -91.07B | -565M -486M -444M -424M -777M -54.18B -790M -5.33B -2.06B -25.72B -2.12B -2.07B -89.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 102.18 $ | -3.19% | 560,751 |
| 26-05-14 | 105.55 $ | +1.61% | 426,527 |
| 26-05-13 | 103.88 $ | +3.93% | 518,200 |
| 26-05-12 | 99.95 $ | -3.43% | 645,725 |
| 26-05-11 | 103.50 $ | +4.17% | 572,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition